메뉴 건너뛰기




Volumn 6, Issue 2, 2011, Pages 237-248

Progress towards a universal influenza vaccine

Author keywords

conserved antigen; epitope; influenza; M2e; pandemic; peptide; seasonal; vaccines

Indexed keywords

ACAM FLU A; ACAMFLU A; AMANTADINE; CHICKENPOX VACCINE; DNA VACCINE; EPITOPE BASED VACCINE; FLU V; FP 01; GAMMAFLU; INFLUENZA VACCINE; LIVE VACCINE; M 001; MATRIX 2 ECTODOMAIN; MEASLES MUMPS RUBELLA VACCINE; MULTIMERIC 001; MULTIPLE; N 8295; NUCLEOPROTEIN; PEPTIDE VACCINE; POLIOMYELITIS VACCINE; RIMANTADINE; TRIPLE VACCINE; UNCLASSIFIED DRUG; UNIVERSAL VACCINE; VGX 3400;

EID: 79952588706     PISSN: 17460794     EISSN: None     Source Type: Journal    
DOI: 10.2217/fvl.10.80     Document Type: Review
Times cited : (3)

References (85)
  • 2
    • 77955610504 scopus 로고    scopus 로고
    • The need for quadrivalent vaccine against seasonal influenza
    • Belshe R: The need for quadrivalent vaccine against seasonal influenza. Vaccine 28(Suppl. 4), D45-D53 (2010).
    • (2010) Vaccine , vol.28 , Issue.4
    • Belshe, R.1
  • 4
    • 0020050946 scopus 로고
    • Molecular mechanisms of variation in influenza viruses
    • Webster R, Laver W, Air G, Schild G: Molecular mechanism of variation in influenza viruses. Nature 296(5853), 115-121 (1982). (Pubitemid 12160907)
    • (1982) Nature , vol.296 , Issue.5853 , pp. 115-121
    • Webster, R.G.1    Laver, W.G.2    Air, G.M.3    Schild, G.C.4
  • 7
    • 32044453088 scopus 로고    scopus 로고
    • Antibody response to influenza vaccination in the elderly: A quantitative review
    • DOI 10.1016/j.vaccine.2005.08.105, PII S0264410X05009552
    • Goodwin K, Viboud C, Simonsen L: Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 24(8), 1159-1169 (2006). (Pubitemid 43202262)
    • (2006) Vaccine , vol.24 , Issue.8 , pp. 1159-1169
    • Goodwin, K.1    Viboud, C.2    Simonsen, L.3
  • 8
    • 77954356995 scopus 로고    scopus 로고
    • British society for allergy and clinical immunology guidelines for the management of egg allergy
    • Clark A, Skypala I, Leech S et al.: British society for allergy and clinical immunology guidelines for the management of egg allergy. Clin. Exp. Allergy 40(8), 1116-1129 (2010).
    • (2010) Clin. Exp. Allergy , vol.40 , Issue.8 , pp. 1116-1129
    • Clark, A.1    Skypala, I.2    Leech, S.3
  • 9
    • 77951835408 scopus 로고    scopus 로고
    • Safety of influenza vaccine administration in egg-allergic patients
    • Chung E, Huang L, Schneider L: Safety of influenza vaccine administration in egg-allergic patients. Pediatrics 125(5), E1024-E1030 (2010).
    • (2010) Pediatrics , vol.125 , Issue.5
    • Chung, E.1    Huang, L.2    Schneider, L.3
  • 10
    • 77955907841 scopus 로고    scopus 로고
    • Safe vaccination of patients with egg allergy with an adjuvanted pandemic H1N1 vaccine
    • Gagnon R, Primeau M, Des Roches A et al.: Safe vaccination of patients with egg allergy with an adjuvanted pandemic H1N1 vaccine. J. Allergy Clin. Immunol. 126(2), 317-323 (2010).
    • (2010) J. Allergy Clin. Immunol. , vol.126 , Issue.2 , pp. 317-323
    • Gagnon, R.1    Primeau, M.2    Des Roches, A.3
  • 11
    • 79952180032 scopus 로고    scopus 로고
    • Universal vaccines: Shifting to one for many
    • Cassone A, Rappuoli R: Universal vaccines: shifting to one for many. MBio. 1(1), PII: E00042-10 (2010).
    • (2010) MBio. , vol.1 , Issue.1
    • Cassone, A.1    Rappuoli, R.2
  • 13
    • 77956415891 scopus 로고    scopus 로고
    • Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A H1N1 influenza virus
    • Skountzou I, Koutsonanos D, Kim J et al.: Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virus. J. Immunol. 185(3), 1642-1649 (2010).
    • (2010) J. Immunol. , vol.185 , Issue.3 , pp. 1642-1649
    • Skountzou, I.1    Koutsonanos, D.2    Kim, J.3
  • 14
    • 77954476468 scopus 로고    scopus 로고
    • Cross-reactive neutralizing antibodies directed against pandemic H1N1 2009 virus are protective in a highly sensitive DBA/2 mouse influenza model
    • Boon A, Debeauchamp J, Krauss S et al.: Cross-reactive neutralizing antibodies directed against pandemic H1N1 2009 virus are protective in a highly sensitive DBA/2 mouse influenza model. J. Virol. 84(15), 7662-7667 (2010).
    • (2010) J. Virol. , vol.84 , Issue.15 , pp. 7662-7667
    • Boon, A.1    Debeauchamp, J.2    Krauss, S.3
  • 15
    • 77953295181 scopus 로고    scopus 로고
    • Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus
    • Tu W, Mao H, Zheng J et al.: Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus. J. Virol. 84(13), 6527-6535 (2010).
    • (2010) J. Virol. , vol.84 , Issue.13 , pp. 6527-6535
    • Tu, W.1    Mao, H.2    Zheng, J.3
  • 16
    • 77950831046 scopus 로고    scopus 로고
    • Cytotoxic T cells are the predominant players providing cross-protective immunity induced by g-irradiated influenza A viruses
    • Furuya Y, Chan J, Regner M et al.: Cytotoxic T cells are the predominant players providing cross-protective immunity induced by g-irradiated influenza A viruses. J. Virol. 84(9), 4212-4221 (2010).
    • (2010) J. Virol. , vol.84 , Issue.9 , pp. 4212-4221
    • Furuya, Y.1    Chan, J.2    Regner, M.3
  • 17
    • 0036772366 scopus 로고    scopus 로고
    • A retro-inverso peptide analogue of influenza virus hemagglutinin B-cell epitope 91-108 induces a strong mucosal and systemic immune response and confers protection in mice after intranasal immunization
    • DOI 10.1016/S0161-5890(02)00095-0, PII S0161589002000950
    • Ben-Yedidia T, Beignon A, Partidos C, Muller S, Arnon R: A retro-inverso peptide analogue of influenza virus hemagglutinin B-cell epitope 91-108 induces a strong mucosal and systemic immune response and confers protection in mice after intranasal immunization. Mol. Immunol. 39(5-6), 323-331 (2002). (Pubitemid 35239888)
    • (2002) Molecular Immunology , vol.39 , Issue.5-6 , pp. 323-331
    • Ben-Yedidia, T.1    Beignon, A.-S.2    Partidos, C.D.3    Muller, S.4    Arnon, R.5
  • 19
    • 0031878581 scopus 로고    scopus 로고
    • Protective role of gamma interferon during the recall response to influenza virus
    • Bot A, Bot S, Bona C: Protective role of gamma interferon during the recall response to influenza virus. J. Virol. 72(8), 6637-6645 (1998). (Pubitemid 28323981)
    • (1998) Journal of Virology , vol.72 , Issue.8 , pp. 6637-6645
    • Bot, A.1    Bot, S.2    Bona, C.A.3
  • 20
    • 0022504418 scopus 로고
    • Functional analysis of influenza-specific helper T cell clones in vivo. T cells specific for internal viral proteins provide cognate help for B cell responses to hemagglutinin
    • Scherle P, Gerhard W: Functional analysis of influenza-specific helper T cell clones in vivo. T cells specific for internal viral proteins provide cognate help for B cell responses to hemagglutinin. J. Exp. Med. 164(4), 1114-1128 (1986). (Pubitemid 16031610)
    • (1986) Journal of Experimental Medicine , vol.164 , Issue.4 , pp. 1114-1128
    • Scherle, P.A.1    Gerhard, W.2
  • 21
    • 0019133770 scopus 로고
    • Cell cooperation in antibody responses to influenza virus. I. Priming of helper T cells by internal components of the virion
    • Russell S, Liew F: Cell cooperation in antibody responses to influenza virus. I. Priming of helper T cells by internal components of virion. Eur. J. Immunol. 10(10), 791-796 (1980). (Pubitemid 11245240)
    • (1980) European Journal of Immunology , vol.10 , Issue.10 , pp. 791-796
    • Russell, S.M.1    Liew, F.Y.2
  • 23
    • 0032874490 scopus 로고    scopus 로고
    • A universal influenza A vaccine based on the extracellular domain of the M2 protein
    • DOI 10.1038/13484
    • Neirynck S, Deroo T, Saelens X, Vanlandschoot P, Jou W, Fiers W: A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat. Med. 5(10), 1157-1163 (1999). (Pubitemid 29474420)
    • (1999) Nature Medicine , vol.5 , Issue.10 , pp. 1157-1163
    • Neirynck, S.1    Deroo, T.2    Saelens, X.3    Vanlandschoot, P.4    Jou, W.M.5    Fiers, W.6
  • 24
    • 79952140653 scopus 로고    scopus 로고
    • Influenza virus vaccine based on the conserved hemagglutinin stalk domain
    • PII: E00018-10
    • Steel J, Lowen A, Wang T et al.: Influenza virus vaccine based on the conserved hemagglutinin stalk domain. MBio. 1(1), PII: E00018-10 (2010).
    • (2010) MBio. , vol.1 , Issue.1
    • Steel, J.1    Lowen, A.2    Wang, T.3
  • 25
    • 77956119219 scopus 로고    scopus 로고
    • Induction of broadly neutralizing H1N1 influenza antibodies by vaccination
    • Wei C, Boyington J, Mctamney P et al.: Induction of broadly neutralizing H1N1 influenza antibodies by vaccination. Science 329(5995), 1060-1064 (2010).
    • (2010) Science , vol.329 , Issue.5995 , pp. 1060-1064
    • Wei, C.1    Boyington, J.2    McTamney, P.3
  • 26
    • 77951876927 scopus 로고    scopus 로고
    • Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine
    • Corti D, Suguitan Aj, Pinna D et al.: Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. J. Clin. Invest. 120(5), 1663-1673 (2010).
    • (2010) J. Clin. Invest. , vol.120 , Issue.5 , pp. 1663-1673
    • Corti, D.1    Suguitan, A.J.2    Pinna, D.3
  • 27
    • 38349095360 scopus 로고    scopus 로고
    • Induction of heterosubtypic immunity to influenza virus by intranasal immunization
    • Quan F, Huang C, Compans R, Nguyen H, Kang S: Induction of heterosubtypic immunity to influenza virus by intranasal immunization. J. Virol. 82(3), 1350-1359 (2008).
    • (2008) J. Virol. , vol.82 , Issue.3 , pp. 1350-1359
    • Quan, F.1    Huang, C.2    Compans, R.3    Nguyen, H.4    Kang, S.5
  • 28
    • 33947410779 scopus 로고    scopus 로고
    • Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus
    • DOI 10.1128/JVI.02052-06
    • Quan F, Huang C, Compans R, Kang S: Virus-like ppages vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J. Virol. 81, 3514-3524 (2007). (Pubitemid 46456660)
    • (2007) Journal of Virology , vol.81 , Issue.7 , pp. 3514-3524
    • Quan, F.-S.1    Huang, C.2    Compans, R.W.3    Kang, S.-M.4
  • 29
    • 0018950287 scopus 로고
    • Outcome of influenza infection: Effect of site of initial infection and heterotypic immunity
    • Yetter R, Lehrer S, Ramphal R, Small PJ: Outcome of influenza infection: effect of site of initial infection and heterotypic immunity. Infect. Immun. 29(2), 654-662 (1980). (Pubitemid 10040184)
    • (1980) Infection and Immunity , vol.29 , Issue.2 , pp. 654-662
    • Yetter, R.A.1    Lehrer, S.2    Ramphal, R.3    Small Jr., P.A.4
  • 30
    • 67650457114 scopus 로고    scopus 로고
    • Infection of mice with a human influenza A/ H3N2 virus induces protective immunity against lethal infection with influenza A/ H5N1 virus
    • Kreijtz J, Bodewes R, Van Den Brand J et al.: Infection of mice with a human influenza A/ H3N2 virus induces protective immunity against lethal infection with influenza A/ H5N1 virus. Vaccine 27(36), 4983-4989 (2009).
    • (2009) Vaccine , vol.27 , Issue.36 , pp. 4983-4989
    • Kreijtz, J.1    Bodewes, R.2    Van Den Brand, J.3
  • 31
    • 78651171439 scopus 로고
    • Induction of partial specific heterotypic immunity in mice by a single infection with influenza A virus
    • Schulman J, Kilbourne E: Induction of partial specific heterotypic immunity in mice by a single infection with influenza A virus. J. Bacteriol. 89, 170-174 (1965).
    • (1965) J. Bacteriol. , vol.89 , pp. 170-174
    • Schulman, J.1    Kilbourne, E.2
  • 32
    • 0021926908 scopus 로고
    • Cross-subtype protection in humans during sequential, overlapping, and/or concurrent epidemics caused by H3N2 and H1N1 influenza viruses
    • Sonoguchi T, Naito H, Hara M, Takeuchi Y, Fukumi H: Cross-subtype protection in humans during sequential, overlapping, and/or concurrent epidemics caused by H3N2 and H1N1 influenza viruses. J. Infect. Dis. 151(1), 81-88 (1985). (Pubitemid 15192884)
    • (1985) Journal of Infectious Diseases , vol.151 , Issue.1 , pp. 81-88
    • Sonoguchi, T.1    Naito, H.2    Hara, M.3
  • 33
    • 78149483541 scopus 로고    scopus 로고
    • Cutting edge: CD4 T cells generated from encounter with seasonal influenza viruses and vaccines have broad protein specificity and can directly recognize naturally generated epitopes derived from the live pandemic H1N1 virus
    • Richards K, Topham D, Chaves F, Sant A: Cutting edge: CD4 T cells generated from encounter with seasonal influenza viruses and vaccines have broad protein specificity and can directly recognize naturally generated epitopes derived from the live pandemic H1N1 virus. J. Immunol. 185(9), 4998-5002 (2010).
    • (2010) J. Immunol. , vol.185 , Issue.9 , pp. 4998-5002
    • Richards, K.1    Topham, D.2    Chaves, F.3    Sant, A.4
  • 34
    • 0033564710 scopus 로고    scopus 로고
    • + T lymphocyte memory to influenza a viruses of swine and avian species
    • Jameson J, Cruz J, Terajima M, Ennis F: Human CD8+ and CD4+ T lymphocyte memory to influenza A viruses of swine and avian species. J. Immunol. 162(12), 7578-7583 (1999). (Pubitemid 29277740)
    • (1999) Journal of Immunology , vol.162 , Issue.12 , pp. 7578-7583
    • Jameson, J.1    Cruz, J.2    Terajima, M.3    Ennis, F.A.4
  • 35
    • 77954598512 scopus 로고    scopus 로고
    • Seasonal influenza vaccine provides priming for A/H1N1 immunization
    • 12RE1
    • Del Giudice G, Stittelaar K, Van Amerongen G et al.: Seasonal influenza vaccine provides priming for A/H1N1 immunization. Sci. Transl. Med. 1(12), 12RE1 (2009).
    • (2009) Sci. Transl. Med. , vol.1 , Issue.12
    • Del Giudice, G.1    Stittelaar, K.2    Van Amerongen, G.3
  • 36
    • 70350025172 scopus 로고    scopus 로고
    • Single dose vaccination with as03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults
    • Schwarz T, Horacek T, Knuf M et al.: Single dose vaccination with as03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults. Vaccine 27(45), 6284-6290 (2009).
    • (2009) Vaccine , vol.27 , Issue.45 , pp. 6284-6290
    • Schwarz, T.1    Horacek, T.2    Knuf, M.3
  • 37
    • 33750980717 scopus 로고    scopus 로고
    • Current status of short synthetic peptides as vaccines
    • Hans D, Young P, Fairlie D: Current status of short synthetic peptides as vaccines. Med. Chem. 2(6), 627-646 (2006). (Pubitemid 44741618)
    • (2006) Medicinal Chemistry , vol.2 , Issue.6 , pp. 627-646
    • Hans, D.1    Young, P.R.2    Fairlie, D.P.3
  • 39
    • 0030842457 scopus 로고    scopus 로고
    • Design of peptide and polypeptide vaccines
    • DOI 10.1016/S0958-1669(97)80066-3
    • Ben-Yedidia T, Arnon R: Design of peptide and polypeptide vaccines. Curr. Opin. Biotechnol. 8(4), 442-448 (1997). (Pubitemid 27351281)
    • (1997) Current Opinion in Biotechnology , vol.8 , Issue.4 , pp. 442-448
    • Ben-Yedidia, T.1    Arnon, R.2
  • 40
    • 2942652411 scopus 로고    scopus 로고
    • + T-cell peptide epitope of vaccinia and variola viruses
    • DOI 10.1128/JVI.78.13.7052-7060.2004
    • Snyder J, Belyakov I, Dzutsev A, Lemmonier F, Berzofsky J: Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses. J. Virol. 78, 7052-7060 (2004). (Pubitemid 38781543)
    • (2004) Journal of Virology , vol.78 , Issue.13 , pp. 7052-7060
    • Snyder, J.T.1    Belyakov, I.M.2    Dzutsev, A.3    Lemonnier, F.4    Berzofsky, J.A.5
  • 41
    • 0032977751 scopus 로고    scopus 로고
    • Synergistic effect of immunization with a peptide cocktail including antibody, helper and cytotoxic T-cell responses on protection against respiratory syncytial virus
    • Hsu S, Chargelegue D, Obeid O, Steward M: Synergistic effect of immunization with a peptide cocktail inducing antibody, helper and cytotoxic T-cell responses on protection against respiratory syncytial virus. J. Gen. Virol. 80(Pt 6), 1401-1405 (1999). (Pubitemid 29261470)
    • (1999) Journal of General Virology , vol.80 , Issue.6 , pp. 1401-1405
    • Hsu, S.-C.1    Chargelegue, D.2    Obeid, O.E.3    Steward, M.W.4
  • 42
    • 37349026910 scopus 로고    scopus 로고
    • Viral peptide immunogens: Current challenges and opportunities
    • DOI 10.1002/psc.896
    • Azizi A, Diaz-Mitoma F: Viral peptide immunogens: current challenges and opportunities. J. Pept. Sci. 13(12), 776-786 (2007). (Pubitemid 350303215)
    • (2007) Journal of Peptide Science , vol.13 , Issue.12 , pp. 776-786
    • Azizi, A.1    Diaz-Mitoma, F.2
  • 43
    • 0037157260 scopus 로고    scopus 로고
    • Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21
    • DOI 10.1016/S0264-410X(02)00115-9, PII S0264410X02001159
    • Kashala O, Amador R, Valero M et al.: Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine spf66 combined with the immunological adjuvant qs-21. Vaccine 20(17-18), 2263-2277 (2002). (Pubitemid 34497037)
    • (2002) Vaccine , vol.20 , Issue.17-18 , pp. 2263-2277
    • Kashala, O.1    Amador, R.2    Valero, M.V.3    Moreno, A.4    Barbosa, A.5    Nickel, B.6    Daubenberger, C.A.7    Guzman, F.8    Pluschke, G.9    Patarroyo, M.E.10
  • 44
    • 0033787408 scopus 로고    scopus 로고
    • Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes
    • Nardin E, Oliveira G, Calvo-Calle J et al.: Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes. J. Infect. Dis. 182(5), 1486-1496 (2000).
    • (2000) J. Infect. Dis. , vol.182 , Issue.5 , pp. 1486-1496
    • Nardin, E.1    Oliveira, G.2    Calvo-Calle, J.3
  • 48
    • 77955555710 scopus 로고    scopus 로고
    • Genetic control of immune responses to influenza A matrix 2 protein M2
    • Misplon J, Lo C, Gabbard J, Tompkins S, Epstein S: Genetic control of immune responses to influenza A matrix 2 protein (M2).Vaccine 28(36), 5817-5827 (2010).
    • (2010) Vaccine , vol.28 , Issue.36 , pp. 5817-5827
    • Misplon, J.1    Lo, C.2    Gabbard, J.3    Tompkins, S.4    Epstein, S.5
  • 49
    • 18944394124 scopus 로고    scopus 로고
    • Induction of effective and antigen-specific antitumour immunity by a liposomal ErbB2/HER2 peptide-based vaccination construct
    • DOI 10.1038/sj.bjc.6602526
    • Roth A, Rohrbach F, Weth R, Frisch B, Schuber F, Wels W: Induction of effective and antigen-specific antitumour immunity by a liposomal erbb2/her2 peptide-based vaccination construct. Br. J. Cancer 92(8), 1421-1429 (2005). (Pubitemid 40705009)
    • (2005) British Journal of Cancer , vol.92 , Issue.8 , pp. 1421-1429
    • Roth, A.1    Rohrbach, F.2    Weth, R.3    Frisch, B.4    Schuber, F.5    Wels, W.S.6
  • 50
    • 21744436442 scopus 로고    scopus 로고
    • Enhanced HIV-1 specific immune response by CpG ODN and HIV-1 immunogen-pulsed dendritic cells confers protection in the Trimera murine model of HIV-1 infection
    • DOI 10.1096/fj.04-3185fje
    • Ayash-Rashkovsky M, Borkow G, Davis H, Moss R, Bartholomew R, Bentwich Z: Enhanced HIV-1 specific immune response by CPG ODN and HIV-1 immunogen-pulsed dendritic cells confers protection in the trimera murine model of HIV-1 infection. FASEB J. 19(9), 1152-1154 (2005). (Pubitemid 40946448)
    • (2005) FASEB Journal , vol.19 , Issue.9 , pp. 1152-1154
    • Ayash-Rashkovsky, M.1    Borkow, G.2    Davis, H.L.3    Moss, R.B.4    Bartholomew, R.5    Bentwich, Z.6
  • 51
    • 31844436647 scopus 로고    scopus 로고
    • Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis
    • DOI 10.1128/IAI.74.2.1113-1120.2006
    • Honko A, Sriranganathan N, Lees C, Mizel S: Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis. Infect. Immun. 74(2), 1113-1120 (2006). (Pubitemid 43185549)
    • (2006) Infection and Immunity , vol.74 , Issue.2 , pp. 1113-1120
    • Honko, A.N.1    Sriranganathan, N.2    Lees, C.J.3    Mizel, S.B.4
  • 52
    • 2142810269 scopus 로고    scopus 로고
    • Influenza A Vaccine Based on the Extracellular Domain of M2: Weak Protection Mediated via Antibody-Dependent NK Cell Activity
    • Jegerlehner A, Schmitz N, Storni T, Bachmann M: Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity. J. Immunol. 172, 5598-5605 (2004). (Pubitemid 38542062)
    • (2004) Journal of Immunology , vol.172 , Issue.9 , pp. 5598-5605
    • Jegerlehner, A.1    Schmitz, N.2    Storni, T.3    Bachmann, M.F.4
  • 55
    • 0032813525 scopus 로고    scopus 로고
    • Intranasal administration of peptide vaccine protects human/mouse radiation chimera from influenza infection
    • DOI 10.1093/intimm/11.7.1043
    • Ben-Yedidia T, Marcus H, Reisner Y, Arnon R: Intranasal administration of peptide vaccine protects human/mouse radiation chimera from influenza infection. Int. Immunol. 11, 1043-1051 (1999). (Pubitemid 29338745)
    • (1999) International Immunology , vol.11 , Issue.7 , pp. 1043-1051
    • Ben-Yedidia, T.1    Marcus, H.2    Reisner, Y.3    Arnon, R.4
  • 56
    • 61549132283 scopus 로고    scopus 로고
    • A universal epitope-based influenza vaccine and its efficacy against H5N1
    • Adar Y, Singer Y, Levi R et al.: A universal epitope-based influenza vaccine and its efficacy against H5N1. Vaccine 27(15), 2099-2107 (2009).
    • (2009) Vaccine , vol.27 , Issue.15 , pp. 2099-2107
    • Adar, Y.1    Singer, Y.2    Levi, R.3
  • 57
    • 48249088136 scopus 로고    scopus 로고
    • Vaccines for pandemic influenza the history of our current vaccines their limitations and the requirements to deal with a pandemic threat
    • Hampson A: Vaccines for pandemic influenza. The history of our current vaccines, their limitations and the requirements to deal with a pandemic threat. Ann. Acad. Med. Singapore 37(6), 510-517 (2008).
    • (2008) Ann. Acad. Med. Singapore , vol.37 , Issue.6 , pp. 510-517
    • Hampson, A.1
  • 58
    • 47349125949 scopus 로고    scopus 로고
    • Cell-based influenza vaccines: Progress to date
    • DOI 10.2165/00003495-200868110-00002
    • Audsley J, Tannock G: Cell-based influenza vaccines: progress to date. Drugs 68(11), 1483-1491 (2008). (Pubitemid 352001186)
    • (2008) Drugs , vol.68 , Issue.11 , pp. 1483-1491
    • Audsley, J.M.1    Tannock, G.A.2
  • 59
    • 72049127925 scopus 로고    scopus 로고
    • Prioritization of pandemic influenza vaccine: Rationale and strategy for decision making
    • Schwartz B, Orenstein W: Prioritization of pandemic influenza vaccine: rationale and strategy for decision making. Curr. Top. Microbiol. Immunol. 333, 495-507 (2009).
    • (2009) Curr. Top. Microbiol. Immunol. , vol.333 , pp. 495-507
    • Schwartz, B.1    Orenstein, W.2
  • 63
    • 57349119130 scopus 로고    scopus 로고
    • Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans
    • Assarsson E, Bui H, Sidney J et al.: Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans. J. Virol. 82(24), 12241-12251 (2008).
    • (2008) J. Virol. , vol.82 , Issue.24 , pp. 12241-12251
    • Assarsson, E.1    Bui, H.2    Sidney, J.3
  • 64
    • 78651096072 scopus 로고    scopus 로고
    • Innovative bioinformatic approaches for developing peptide-based vaccines against hypervariable viruses
    • Sirskyj D, Diaz-Mitoma F, Golshani A, Kumar A, Azizi A: Innovative bioinformatic approaches for developing peptide-based vaccines against hypervariable viruses. Immunol. Cell Biol. 89(1), 81-89 (2011).
    • (2011) Immunol. Cell Biol. , vol.89 , Issue.1 , pp. 81-89
    • Sirskyj, D.1    Diaz-Mitoma, F.2    Golshani, A.3    Kumar, A.4    Azizi, A.5
  • 65
    • 0029897044 scopus 로고    scopus 로고
    • Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs
    • DOI 10.1016/0167-5699(96)80542-1
    • Sidney J, Grey H, Kubo R, Sette A: Practical, biochemical and evolutionary implication of the discovery of HLA class I supermotifs. Immunol. Today 17, 261-266 (1996). (Pubitemid 26183489)
    • (1996) Immunology Today , vol.17 , Issue.6 , pp. 261-266
    • Sidney, J.1    Grey, H.M.2    Kubo, R.T.3    Sette, A.4
  • 66
    • 0035879093 scopus 로고    scopus 로고
    • Identification of new epitopes from four different tumor-associated antigens: Recognition of naturally processed epitopes correlates with HLA-A*0201-binding affinity
    • Keogh E, Fikes J, Southwood S, Celis E, Chesnut R, Sette A: Identification of new epitopes from four different tumor-associated antigens: recognition of naturally processed epitopes correlates with HLA-A0201-binding affinity. J. Immunol. 167(2), 787-796 (2001). (Pubitemid 32660833)
    • (2001) Journal of Immunology , vol.167 , Issue.2 , pp. 787-796
    • Keogh, E.1    Fikes, J.2    Southwood, S.3    Celis, E.4    Chesnut, R.5    Sette, A.6
  • 67
    • 33750601397 scopus 로고    scopus 로고
    • Towards an epitope-based human vaccine for influenza
    • Ben-Yedidia T, Arnon R: Towards an epitope-based human vaccine for influenza. Hum. Vaccin. 1(3), 95-101 (2005).
    • (2005) Hum. Vaccin. , vol.1 , Issue.3 , pp. 95-101
    • Ben-Yedidia, T.1    Arnon, R.2
  • 71
    • 7744239182 scopus 로고    scopus 로고
    • High epitope density in a single recombinant protein molecule of the extracellular domain of influenza a virus M2 protein significantly enhances protective immunity
    • Wanli L, Zou P, Zuqiang L, Yun L, Jian D, Ying-Hua C: High epitope density in a single recombinant protein molecule of the extracellular domain of influenza A virus M2 protein significantly enhances protective immunity. Vaccine 23, 366-371 (2004).
    • (2004) . Vaccine , vol.23 , pp. 366-371
    • Wanli, L.1    Zou, P.2    Zuqiang, L.3    Yun, L.4    Jian, D.5    Ying-Hua, C.6
  • 72
    • 2442519025 scopus 로고    scopus 로고
    • Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes
    • DOI 10.1016/j.virusres.2004.02.020, PII S0168170204001194
    • Rimmelzwaan G, Boon A, Voeten J, Berkhoff E, Fouchier R, Osterhaus A: Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes. Virus Res. 103(1-2), 97-100 (2004). (Pubitemid 38649067)
    • (2004) Virus Research , vol.103 , Issue.1-2 , pp. 97-100
    • Rimmelzwaan, G.F.1    Boon, A.C.M.2    Voeten, J.T.M.3    Berkhoff, E.G.M.4    Fouchier, R.A.M.5    Osterhaus, A.D.M.E.6
  • 73
    • 63449125762 scopus 로고    scopus 로고
    • Cross-protective potential of a novel monoclonal antibody directed against antigenic site b of the hemagglutinin of influenza a viruses
    • Yoshida R, Igarashi M, Ozaki H et al.: Cross-protective potential of a novel monoclonal antibody directed against antigenic site b of the hemagglutinin of influenza A viruses. PLoS Pathog. 5(3), E1000350 (2009).
    • (2009) PLoS Pathog. , vol.5 , Issue.3
    • Yoshida, R.1    Igarashi, M.2    Ozaki, H.3
  • 74
    • 64849114224 scopus 로고    scopus 로고
    • Antibody recognition of a highly conserved influenza virus epitope
    • Ekiert D, Bhabha G, Elsliger M et al.: Antibody recognition of a highly conserved influenza virus epitope. Science 324(5924), 246-251 (2009).
    • (2009) Science , vol.324 , Issue.5924 , pp. 246-251
    • Ekiert, D.1    Bhabha, G.2    Elsliger, M.3
  • 75
    • 79251571764 scopus 로고    scopus 로고
    • Attaching zanamivir to a polymer markedly enhances its activity against drug-resistant strains of influenza A virus
    • Weight AK, Halder J, Alvarez de Cienfuegos L et al.: Attaching zanamivir to a polymer markedly enhances its activity against drug-resistant strains of influenza A virus. J. Pharm. Sci. 100(3), 831-835 (2011).
    • (2011) J. Pharm. Sci. , vol.100 , Issue.3 , pp. 831-835
    • Weight, A.K.1    Halder, J.2    Alvarez De Cienfuegos, L.3
  • 77
    • 71149097661 scopus 로고    scopus 로고
    • A practical influenza neutralization assay to simultaneously quantify hemagglutinin and neuraminidase-inhibiting antibody responses
    • Hassantoufighi A, Zhang H, Sandbulte M et al.: A practical influenza neutralization assay to simultaneously quantify hemagglutinin and neuraminidase-inhibiting antibody responses. Vaccine 28(3), 790-797 (2010).
    • (2010) Vaccine , vol.28 , Issue.3 , pp. 790-797
    • Hassantoufighi, A.1    Zhang, H.2    Sandbulte, M.3
  • 78
    • 33646468500 scopus 로고    scopus 로고
    • T cell responses are better correlates of vaccine protection in the elderly
    • Mcelhaney J, Xie D, Hager W et al.: T cell responses are better correlates of vaccine protection in the elderly. J. Immunol. 176, 6333-6339 (2006).
    • (2006) J. Immunol. , vol.176 , pp. 6333-6339
    • McElhaney, J.1    Xie, D.2    Hager, W.3
  • 83
    • 67349085540 scopus 로고    scopus 로고
    • Monoclonal antibody recognizing SLLTEVET epitope of M2 protein potently inhibited the replication of influenza a viruses in MDCK cells
    • Wang Y, Zhou L, Shi H et al.: Monoclonal antibody recognizing SLLTEVET epitope of M2 protein potently inhibited the replication of influenza A viruses in MDCK cells. Biochem. Biophys. Res. Commun. 385(1), 118-122 (2009).
    • (2009) Biochem. Biophys. Res. Commun. , vol.385 , Issue.1 , pp. 118-122
    • Wang, Y.1    Zhou, L.2    Shi, H.3
  • 84
    • 70349967937 scopus 로고    scopus 로고
    • M2e-based universal influenza a vaccine
    • Fiers W, De Filette M, El Bakkouri K et al.: M2e-based universal influenza A vaccine. Vaccine 27(45), 6280-6283 (2009).
    • (2009) Vaccine , vol.27 , Issue.45 , pp. 6280-6283
    • Fiers, W.1    De Filette, M.2    El Bakkouri, K.3
  • 85
    • 77955434077 scopus 로고    scopus 로고
    • Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza a viruses
    • Grandea AG 3rd, Olsen OA, Cox TC et al.: Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses. PNAS 107(28), 12658-12663 (2010).
    • (2010) PNAS , vol.107 , Issue.28 , pp. 12658-12663
    • Grandea III, A.G.1    Olsen, O.A.2    Cox, T.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.